Related Experiment Video
Updated: Jun 4, 2026
07:13
Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads
Published on: June 28, 2024
Engineering monovalent quantum dot-antibody bioconjugates with a hybrid gel system
1Department of Bioengineering, University of Washington, Seattle, Washington 98195, USA.
Bioconjugate Chemistry
|February 26, 2011
Summary
Researchers developed monovalent quantum dot-antibody bioconjugates for precise biological imaging and detection. This new nanoprobe offers improved quantification, advancing in vitro and in vivo applications.
Area of Science:
- Nanotechnology
- Bioconjugation
- Molecular Imaging
Background:
- Monovalent nanoparticles offer stoichiometric binding for enhanced specificity in biological applications.
- Antibodies remain crucial molecular targeting probes in diagnostics and research.
- Previous advantages of monovalent probes over multivalent ones were largely theoretical.
Purpose of the Study:
- To prepare monovalent quantum dot-antibody bioconjugates.
- To demonstrate a broadly applicable method for creating these bioconjugates.
- To provide experimental evidence for improved quantification capabilities.
Main Methods:
- Utilized a high-resolution hybrid gel system for nanoparticle bioconjugate fractionation.
- Developed a method applicable to various nanoparticle-antibody complexes without requiring engineered proteins.
- Performed experimental validation of the monovalent probes' performance.
Main Results:
- Successfully prepared monovalent quantum dot-antibody bioconjugates.
- Demonstrated the broad applicability of the preparation method across different nanoparticle-antibody types.
- Provided experimental evidence confirming improved quantification accuracy compared to multivalent probes.
Conclusions:
- The developed monovalent quantum dot-antibody bioconjugates enable precise stoichiometric binding.
- The novel fractionation technique is versatile and does not require genetically modified proteins.
- These nanoprobes show significant potential for quantitative biological detection and imaging in vitro and in vivo.
Related Concept Videos
01:33Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
01:20Immunogold Electron Microscopy
Immunoelectron microscopy utilizes immunogold labeling of endogenous proteins with specific antibodies to detect and localize these proteins in cells and tissues. The procedure provides insights into the distribution and quantification of protein under different stimulation conditions offering clues about their functions. Conjugating highly electron-dense gold particles with primary or secondary antibodies allow antigen detection on and within cells, with high resolution and specificity.